We are live on ! Find out more
BEAT

BioTelemetry, Inc.
BEAT

Delisted

BEAT was delisted on the 8th of February, 2021.

77 hedge funds and large institutions have $141M invested in BioTelemetry, Inc. in 2013 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 26 increasing their positions, 24 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more call options, than puts

Call options by funds: $2.46M | Put options by funds: $1.68M

11% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 18

3% more funds holding

Funds holding: 7577 (+2)

8% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 24

20% less capital invested

Capital invested by funds: $176M → $141M (-$35.3M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
77
Holders Change
+2
Holders Change %
+2.67%
% of All Funds
2.24%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
20
Increased
26
Reduced
24
Closed
18
Calls
$2.46M
Puts
$1.68M
Net Calls
+$778K
Net Calls Change
-$1.5M
Name Holding Trade Value Shares
Change
Change in
Stake
SKK
51
Shepherd Kaplan Krochuk
Massachusetts
$314K
FMBTD
52
First Midwest Bank Trust Division
Illinois
$294K +$345K +36,973 New
Bank of New York Mellon
53
Bank of New York Mellon
New York
$269K -$729K -78,131 -70%
Connor, Clark & Lunn Investment Management (CC&L)
54
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$268K +$297K +31,800 New
Wells Fargo
55
Wells Fargo
California
$223K -$4.67K -500 -2%
PCM
56
Perkins Capital Management
Minnesota
$197K -$1.38M -148,279 -86%
TDC
57
Thompson Davis & Co
Virginia
$194K +$228K +24,400 New
US Bancorp
58
US Bancorp
Minnesota
$178K -$4.67K -500 -2%
MWNA
59
Marshall Wace North America
New York
$158K +$186K +19,920 New
State Street
60
State Street
Massachusetts
$119K
Goldman Sachs
61
Goldman Sachs
New York
$114K -$40.8K -4,367 -23%
Invesco
62
Invesco
Georgia
$104K -$371K -39,732 -75%
JP Morgan Chase
63
JP Morgan Chase
New York
$88K +$103K +11,077 New
Jane Street
64
Jane Street
New York
$85K -$416K -44,552 -81%
TRCT
65
Tower Research Capital (TRC)
New York
$79K +$71.1K +7,614 +329%
HNB
66
Huntington National Bank
Ohio
$59K +$26.9K +2,887 +64%
NFA
67
Nationwide Fund Advisors
Ohio
$57K
TI
68
Trigran Investments
Illinois
$56K -$3.93M -420,560 -98%
LTFS
69
Ladenburg Thalmann Financial Services
Florida
$37K +$14.9K +1,600 +53%
AIG
70
American International Group
New York
$31.8K +$37.3K +4,000 New
Barclays
71
Barclays
United Kingdom
$12K -$6.18K -662 -28%
GT
72
Glenmede Trust
Pennsylvania
$10K +$4.26K +456 +50%
Deutsche Bank
73
Deutsche Bank
Germany
$7K -$1.22K -131 -12%
BJ
74
BlackRock Japan
Japan
$6K +$6.58K +705 New
Royal Bank of Canada
75
Royal Bank of Canada
Ontario, Canada
$4K +$4.67K +500 New

BEAT Hedge Fund Activity: Q4 2013 in Review

77 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry, Inc. (BEAT) for Q4 2013, worth a combined $141M — down 20% from $176M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new BEAT positions and 18 closed out — a net gain of 2 holders — while 26 added to existing stakes and 24 trimmed.

The largest buyer was Cortina Asset Management, opening a new position worth an estimated $9.15M. The largest seller was Balyasny Asset Management, exiting entirely with an estimated $9.9M sold.

  • 77 institutional investors held BioTelemetry, Inc. (BEAT) as of Q4 2013, up from 75 in Q3 2013.
  • Funds reported $141M of BioTelemetry, Inc. stock for Q4 2013, down 20% quarter-over-quarter.
  • 20 funds opened new BioTelemetry, Inc. positions in Q4 2013 and 18 closed out, a net change of +2 holders.
  • The largest BioTelemetry, Inc. buyer in Q4 2013 was Cortina Asset Management, an estimated $9.15M added.
  • The largest BioTelemetry, Inc. seller in Q4 2013 was Balyasny Asset Management, an estimated $9.9M sold.

Based on aggregated 13F filings for Q4 2013.